These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27531748)

  • 1. Hypoxia and Transforming Growth Factor β Cooperate to Induce Fibulin-5 Expression in Pancreatic Cancer.
    Topalovski M; Hagopian M; Wang M; Brekken RA
    J Biol Chem; 2016 Oct; 291(42):22244-22252. PubMed ID: 27531748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibulin-5 Blocks Microenvironmental ROS in Pancreatic Cancer.
    Wang M; Topalovski M; Toombs JE; Wright CM; Moore ZR; Boothman DA; Yanagisawa H; Wang H; Witkiewicz A; Castrillon DH; Brekken RA
    Cancer Res; 2015 Dec; 75(23):5058-69. PubMed ID: 26577699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibulin-5 gene expression in human lung fibroblasts is regulated by TGF-beta and phosphatidylinositol 3-kinase activity.
    Kuang PP; Joyce-Brady M; Zhang XH; Jean JC; Goldstein RH
    Am J Physiol Cell Physiol; 2006 Dec; 291(6):C1412-21. PubMed ID: 16837650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of fibulin-5 binding to beta1 integrins inhibits tumor growth by increasing the level of ROS.
    Schluterman MK; Chapman SL; Korpanty G; Ozumi K; Fukai T; Yanagisawa H; Brekken RA
    Dis Model Mech; 2010; 3(5-6):333-42. PubMed ID: 20197418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma.
    Thakur AK; Nigri J; Lac S; Leca J; Bressy C; Berthezene P; Bartholin L; Chan P; Calvo E; Iovanna JL; Vasseur S; Guillaumond F; Tomasini R
    Cell Death Differ; 2016 Aug; 23(8):1358-70. PubMed ID: 26943320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibulin-5 is up-regulated by hypoxia in endothelial cells through a hypoxia-inducible factor-1 (HIF-1α)-dependent mechanism.
    Guadall A; Orriols M; Rodríguez-Calvo R; Calvayrac O; Crespo J; Aledo R; Martínez-González J; Rodríguez C
    J Biol Chem; 2011 Mar; 286(9):7093-103. PubMed ID: 21193390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition of cell proliferation and induction of apoptosis in pancreatic ductal adenocarcinoma cells by verrucarin A, a macrocyclic trichothecene, is associated with the inhibition of Akt/NF-кB/mTOR prosurvival signaling.
    Deeb D; Gao X; Liu Y; Zhang Y; Shaw J; Valeriote FA; Gautam SC
    Int J Oncol; 2016 Sep; 49(3):1139-47. PubMed ID: 27573873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression.
    Laklai H; Miroshnikova YA; Pickup MW; Collisson EA; Kim GE; Barrett AS; Hill RC; Lakins JN; Schlaepfer DD; Mouw JK; LeBleu VS; Roy N; Novitskiy SV; Johansen JS; Poli V; Kalluri R; Iacobuzio-Donahue CA; Wood LD; Hebrok M; Hansen K; Moses HL; Weaver VM
    Nat Med; 2016 May; 22(5):497-505. PubMed ID: 27089513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embigin is overexpressed in pancreatic ductal adenocarcinoma and regulates cell motility through epithelial to mesenchymal transition via the TGF-β pathway.
    Jung DE; Kim JM; Kim C; Song SY
    Mol Carcinog; 2016 May; 55(5):633-45. PubMed ID: 25773908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism.
    Lee YH; Albig AR; Regner M; Schiemann BJ; Schiemann WP
    Carcinogenesis; 2008 Dec; 29(12):2243-51. PubMed ID: 18713838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin α11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer.
    Schnittert J; Bansal R; Mardhian DF; van Baarlen J; Östman A; Prakash J
    FASEB J; 2019 May; 33(5):6609-6621. PubMed ID: 30808244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells.
    Ji Z; Mei FC; Xie J; Cheng X
    J Biol Chem; 2007 May; 282(19):14048-55. PubMed ID: 17353198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel 3-dimensional culture system uncovers growth stimulatory actions by TGFβ in pancreatic cancer cells.
    Sempere LF; Gunn JR; Korc M
    Cancer Biol Ther; 2011 Aug; 12(3):198-207. PubMed ID: 21613822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway.
    Baril P; Gangeswaran R; Mahon PC; Caulee K; Kocher HM; Harada T; Zhu M; Kalthoff H; Crnogorac-Jurcevic T; Lemoine NR
    Oncogene; 2007 Mar; 26(14):2082-94. PubMed ID: 17043657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-cadherin haploinsufficiency increases survival in a mouse model of pancreatic cancer.
    Su Y; Li J; Witkiewicz AK; Brennan D; Neill T; Talarico J; Radice GL
    Oncogene; 2012 Oct; 31(41):4484-9. PubMed ID: 22158044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix control of pancreatic cancer: New insights into fibronectin signaling.
    Topalovski M; Brekken RA
    Cancer Lett; 2016 Oct; 381(1):252-8. PubMed ID: 26742464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
    Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
    Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of transforming growth factor beta-induced in circulating tumor cell subline from pancreatic cancer cell line.
    Sato T; Muramatsu T; Tanabe M; Inazawa J
    Cancer Sci; 2018 Nov; 109(11):3623-3633. PubMed ID: 30156359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Par-4 mediated Smad4 induction in PDAC cells restores canonical TGF-β/ Smad4 axis driving the cells towards lethal EMT.
    Mohd Faheem M; Rasool RU; Ahmad SM; Jamwal VL; Chakraborty S; Katoch A; Gandhi SG; Bhagat M; Goswami A
    Eur J Cell Biol; 2020 May; 99(4):151076. PubMed ID: 32439219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.